Feasibility study of a lead monoxide-based dosimeter for quality assurance in radiotherapy

Lately, cancer has been treated using high-energy radiation, and this requires highly reliable treatment plans. Therefore, a dosimeter with excellent performance, which is capable of precise dose measurement, is critical. In current clinical practices, an ionization chamber and diode utilizing the ionization reaction mechanism are widely used. Several studies have been carried out to determine optimal materials for the detector in a dosimeter to enable diagnostic imaging. Recently, studies with lead monoxide, which was shown to have low drift current and high resolving power at a high bias, were reported with the dosimeter exhibiting a fast response time against incident photons. This research aims to investigate the feasibility of a lead monoxide-based dosimeter for QA (quality assurance) in radiotherapy. In this paper, we report that the manufactured dosimeter shows similar linearity to a silicon diode and demonstrates similar characteristics in terms of PDD (percent depth dose) results for the thimble ionization chamber. Based on these results, it is demonstrated that the lead monoxide-based dosimeter complies with radiotherapy QA requirements, namely rapid response time, dose linearity, dose rate independence. Thus, we expect the lead monoxide-based dosimeter to be used commercially in the future.